Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 8-K Quarterly results
Docs: "PacBio Announces Second Quarter 2023 Financial Results",
"PacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer PacBio will combine Apton’s proprietary sequencing technology with its highly accurate Sequencing by Binding chemistry to develop a high-throughput sequencer designed to deliver billions of reads per flow cell",
"PacBio Begins Commercialization of the Onso Short-Read Sequencing System The Onso platform delivers extraordinary accuracy which creates new possibilities for research and translational sequencing applications"
06/30/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Indenture, by and between Pacific Biosciences of California, Inc. and U.S. Bank Trust Company, National Association, as Trustee"
05/26/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
01/27/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement",
"Re: Registration Statement on Form S-3",
"Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock"
01/24/2023 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock",
"Disclosure Update as of January 24, 2023",
"Letter Relating to Employment Terms by and between the Registrant and Jeff Eidel effective August 16, 2022",
"Change in Control and Severance Agreement by and between the Registrant and Susan G. Kim effective February 3, 2021"
01/09/2023 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Exhibit 99.1 PacBio Announces Record Orders, Including Orders for 76 Revio Systems Received in the Fourth Quarter of 2022"
11/07/2022 8-K Quarterly results
Docs: "THIRD AMENDED AND RESTATED BYLAWS OF PACIFIC BIOSCIENCES OF CALIFORNIA, INC.",
"PacBio Announces Third Quarter 2022 Financial Results"
10/25/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
08/03/2022 8-K Quarterly results
Docs: "PacBio Announces Second Quarter 2022 Financial Results"
06/30/2022 8-K Quarterly results
05/26/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2020 EQUITY INCENTIVE PLAN",
"NOTICE OF STOCK OPTION GRANT",
"NOTICE OF RESTRICTED STOCK UNIT GRANT"
05/17/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
Docs: "PacBio Announces First Quarter 2022 Financial Results"
02/15/2022 8-K Results of Operations and Financial Condition  Interactive Data
Docs: "PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results"
01/11/2022 8-K Results of Operations and Financial Condition  Interactive Data
Docs: "Exhibit 99.1 PacBio Announces Record Preliminary Fourth Quarter 2021 Revenue, New Sequencing Kits and Workflows, and Expanded Collaborations"
11/19/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "passport or other identification number , salary, nationality, job title, any Shares or directorships held in the Company, details of all equity awards or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor , for the exclusive purpose of implementing, administering and managing the Plan. Participant understands that Data may be transferred to a stock plan service provider, as may be selected by the Company in the future, assisting the Company with the implementation, administration and management of the Plan. Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country of operation may have different data privacy laws and protections than Participan..."
11/02/2021 8-K Quarterly results
Docs: "PacBio Announces Third Quarter 2021 Financial Results"
09/20/2021 8-K Quarterly results
09/10/2021 8-K Quarterly results
08/03/2021 8-K Quarterly results
Docs: "Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial Results"
07/20/2021 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Unregistered Sales of Equity Secur...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Agreement and Plan of Merger and Plan of Reorganization among Pacific Biosciences of California, Inc., Apollo Merger Sub, Inc., Apollo Acquisition Sub, LLC, Omniome, Inc. and Shareholder Representative Services, LLC, as securityholder representative",
"Securities Purchase Agreement, by and between Pacific Biosciences of California, Inc. and each of the Investors",
"Registration Rights Agreement, by and between Pacific Biosciences of California, Inc. and each of the Investors",
"Pacific Biosciences Signs Definitive Agreement to Acquire Omniome"
06/17/2021 8-K Quarterly results
05/14/2021 8-K Quarterly results
04/29/2021 8-K Quarterly results
04/27/2021 8-K Quarterly results
04/19/2021 8-K Quarterly results
02/16/2021 8-K Quarterly results
02/10/2021 8-K Quarterly results
02/10/2021 8-K Quarterly results
02/09/2021 8-K Quarterly results
01/13/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
01/08/2021 8-K Quarterly results
12/04/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Consentement Relatif à la Langue Utilisée. En acceptant le Contrat d’Attribution décrivant les termes et conditions de l’attribution, le Participant confirme avoir lu et compris les documents relatifs à cette attribution qui ont été communiqués en langue anglaise. Le Participant accepte les termes de ces documents en connaissance de cause. Notifications Foreign Asset/Account Reporting Information. Participant may hold Shares acquired under the Plan outside of France provided Participant annually declares all foreign bank and stock accounts, whether open, current, or closed, together with Participant’s personal income tax returns. Germany Notifications Exchange Control Information. Cross-border payments in excess of €12,500 must be reported electron..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy